![Mark Versavel](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profiel
Mark Versavel is the founder of Vzenium LLC.
He previously worked as the Chief Medical Officer at Cavion, Inc., Alzheon, Inc., and NeuroBo Pharmaceuticals, Inc. In 2023, he held the position of Chief Medical Officer at Eliem Therapeutics, Inc. Dr. Versavel obtained an MBA from the University of Michigan in 2003.
He also earned a doctorate degree from Humboldt-Universität zu Berlin in 2003 and another doctorate degree from the University of Antwerp in 1983.
Actieve functies van Mark Versavel
| Bedrijven | Functie | Begin |
|---|---|---|
Vzenium LLC | Oprichter | - |
Eerdere bekende functies van Mark Versavel
| Bedrijven | Functie | Einde |
|---|---|---|
| CLIMB BIO, INC. | Hoofd Techniek/Wetenschap/O&O | 01-10-2023 |
Cavion, Inc.
 Cavion, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes oncology drugs for solid tumors | Hoofd Techniek/Wetenschap/O&O | - |
| METAVIA INC. | Hoofd Techniek/Wetenschap/O&O | - |
| ALZHEON, INC. | Hoofd Techniek/Wetenschap/O&O | - |
Opleiding van Mark Versavel
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
98
Eerstegraads connecties
8
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 8 |
|---|---|
Cavion, Inc.
Cavion, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes oncology drugs for solid tumors | Health Technology |
Alzheon, Inc.
 Alzheon, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company that develops drugs for neurodegenerative disorders | Health Technology |
University of Michigan
 University of Michigan Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Humboldt-Universität zu Berlin
 Humboldt-Universität zu Berlin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Antwerp
 University of Antwerp Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Eliem Therapeutics, Inc.
 Eliem Therapeutics, Inc. BiotechnologyHealth Technology Operates as clinical-stage biotechnology company focused on developing novel therapies for neuronal excitability disorders | Health Technology |
NeuroBo Pharmaceuticals, Inc.
 NeuroBo Pharmaceuticals, Inc. BiotechnologyHealth Technology Researches and develops disease-modifying therapies for neurodegenerative diseases | Health Technology |
Vzenium LLC |
Kies MarketScreener 
